Filter
986
Filtered Results: 986
Text search:
pharmaceutical
procurement
Featured
Recommendations
106
New Publications
307
Language
Document type
No document type
508
Studies & Reports
181
Guidelines
152
Strategic & Response Plan
59
Manuals
44
Fact sheets
18
Training Material
10
Situation Updates
9
Resource Platforms
3
Brochures
1
Infographics
1
Countries / Regions
Ethiopia
55
Kenya
50
Global
34
India
33
Uganda
28
South Africa
26
Sierra Leone
25
Nigeria
23
Liberia
23
Ghana
20
Malawi
19
Tanzania
19
Nepal
17
Rwanda
17
Western and Central Europe
16
Zambia
16
Bangladesh
14
Ukraine
13
Namibia
13
Zimbabwe
12
Philippines
12
Africa
12
Lesotho
11
Eastern Europe
9
Syria
8
Cambodia
8
Senegal
7
Latin America and the Carribbean
7
Congo, Democratic Republic of
7
Myanmar / Burma
7
Botswana
6
Indonesia
6
Eswatini/ Swaziland
6
Benin
5
Cameroon
5
Burkina Faso
5
Asia
5
South–East Asia Region
5
Haiti
4
West and Central Africa
4
East and Southern Africa
4
Guinea
3
Mozambique
3
North America
3
Papua New Guinea
3
Sudan
3
Thailand
2
Albania
2
Jordan
2
Middle East and North Africa
2
Western Pacific Region
2
Lebanon
2
Yemen
2
South Sudan
2
Pakistan
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Fiji
1
Laos
1
Germany
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
Paraguay
1
Gabon
1
Maldives
1
Southern Africa
1
Brazil
1
Moldova
1
Russia
1
Central African Republic
1
Mali
1
Libya
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
492
Clinical Guidelines
58
Key Resources
46
Public Health
38
Pharmacy & Technologies
23
Women & Child Health
22
Capacity Building
5
Annual Report MEDBOX
1
Toolboxes
Pharmacy
109
AMR
95
COVID-19
65
HIV
58
TB
52
Rapid Response
26
NTDs
24
Health Financing Toolbox
22
Planetary Health
20
Conflict
16
NCDs
15
Global Health Education
13
Mental Health
11
Ebola & Marburg
11
Caregiver
9
Natural Hazards
4
Polio
3
Refugee
2
Disability
2
Cholera
2
Specific Hazards
1
Zika
1
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Agodokpessi et al. Journal of Pharmaceutical Policy and Practice (2015) 8:12DOI 10.1186/s40545-015-0033-7
Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated
the operation of the RDF and assessed whether there was interruption of supply of asthma me...
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
Recommendations for step-wise implementation
STGs are designed to assist health care professionals in making decisions about appropriate, effective patient care. However, health managers often have trouble setting and meeting the high standards required of modern, developed health care systems. With stakeholders expressing concern over issues ...
WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of medicines on behalf of the patients they serve. The role of FIP is to provide leadership for na...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T...
English version - This handbook sets out a the new paradigm for pharmacy practice. Its aim is to guide pharmacy educators in pharmacy practice, to educate pharmacy students and to guide pharmacists in practice to update their skills. The handbook, which brings together practical tools and knowledge,...
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and use of medicines for children. It is a resource for ...
PURPOSE: To assess the appropriateness of computerizing a health facility warehouse. If users are interested in receiving technical assistance to improve and/or computerize the logistics information system, Management Sciences for Health (MSH) will analyze the responses to determine the initial step...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
Guidelines for Handling Temperature Sensitive Vaccines and Pharmaceuticals
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
World Journal of Pharmaceutical and Medical Research vol. 5 (2019) 3, 129-132
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there...
